These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A magic bullet for cancer--how near and how far? Schnipper LE; Strom TB N Engl J Med; 2001 Jul; 345(4):283-4. PubMed ID: 11474668 [No Abstract] [Full Text] [Related]
9. [Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy]. Renner C; Pfreundschuh M Fortschr Med; 1994 Oct; 112(29):399. PubMed ID: 8001887 [No Abstract] [Full Text] [Related]
10. Antibody conjugates for the treatment of cancer. Pietersz GA; McKenzie IF Immunol Rev; 1992 Oct; 129():57-80. PubMed ID: 1464422 [No Abstract] [Full Text] [Related]
11. Targeted delivery of biologic and other antineoplastic agents. Rowlinson-Busza G; Epenetos AA Curr Opin Oncol; 1992 Dec; 4(6):1142-8. PubMed ID: 1457528 [TBL] [Abstract][Full Text] [Related]
12. Antibodies and peptides in cancer therapy. Khandare JJ; Minko T Crit Rev Ther Drug Carrier Syst; 2006; 23(5):401-35. PubMed ID: 17425513 [TBL] [Abstract][Full Text] [Related]
13. [Cancer therapy by using bispecific antibody]. Azuma A; Niitani H; Okumura K Gan To Kagaku Ryoho; 1991 Aug; 18(10):1535-42. PubMed ID: 1872618 [TBL] [Abstract][Full Text] [Related]
18. Current status of antibody-toxin conjugates for tumor therapy. Ramakrishnan S Targeted Diagn Ther; 1990; 3():189-213. PubMed ID: 2131010 [No Abstract] [Full Text] [Related]
19. Monoclonal antibody-conjugated immunotherapy of cancer. Imai K; Hareyama M; Makiguchi Y; Matsumoto H; Hinoda Y Int Rev Immunol; 1997; 14(2-3):213-27. PubMed ID: 9131388 [No Abstract] [Full Text] [Related]
20. Antibody drug conjugates - Trojan horses in the war on cancer. Iyer U; Kadambi VJ J Pharmacol Toxicol Methods; 2011; 64(3):207-12. PubMed ID: 21843648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]